Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cardiology Reviews
  4. Volume 20, Issue 6
  5. Article
Volume 20, Issue 6
  • ISSN: 1573-403X
  • E-ISSN:

Abstract

Female carriers of Duchenne Muscular Dystrophy (DMD) carry a heterozygous pathogenic variant in the dystrophin gene and can transmit pathogenic variants to their offspring. DMD is an X-linked recessive disease that affects up to 19.8 in every 100,000 male births. Those carriers with symptoms can be referred to as women with dystrophinopathy. Even among asymptomatic carriers, cardiac involvement can be verified in between 2.5% and 75% through echocardiography. The most commonly affected wall of the left ventricle is the inferolateral, with myocardial fibrosis detected by cardiac nuclear resonance. Therefore, screening is recommended for these women carriers due to the risk of cardiomyopathy. There is a lack of longitudinal studies on the evolution of these carriers. In this article, data on clinical presentation, cardiac assessment for female patients with dystrophinopathy and DMD carriers, and approaches for these patients are discussed.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X292850240719074112
2024-11-01
2024-11-22

  • From This Site

    /content/journals/ccr/10.2174/011573403X292850240719074112
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MercuriE. BönnemannC.G. MuntoniF. Muscular dystrophies.Lancet2019394102132025203810.1016/S0140‑6736(19)32910‑1 31789220
     [Google Scholar]
  2. DuanD. GoemansN. TakedaS. MercuriE. Aartsma-RusA. Duchenne muscular dystrophy.Nat. Rev. Dis. Primers2021711310.1038/s41572‑021‑00248‑3 33602943
     [Google Scholar]
  3. CrisafulliS. SultanaJ. FontanaA. SalvoF. MessinaS. TrifiròG. Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis.Orphanet J. Rare Dis.202015114110.1186/s13023‑020‑01430‑8 32503598
     [Google Scholar]
  4. SalariN. FatahiB. ValipourE. Global prevalence of Duchenne and Becker muscular dystrophy: A systematic review and meta-analysis.J. Orthop. Surg. Res.20221719610.1186/s13018‑022‑02996‑8 35168641
     [Google Scholar]
  5. EmeryA.E.H. Duchenne muscular dystrophy—Meryon’s disease.Neuromuscul. Disord.19933426326610.1016/0960‑8966(93)90018‑F 8268722
     [Google Scholar]
  6. TylerK.L. Origins and early descriptions of “Duchenne muscular dystrophy”.Muscle Nerve200328440242210.1002/mus.10435 14506712
     [Google Scholar]
  7. AngeliniC. Muscular dystrophy. Handbook of Clinical Neurology200910.1016/S0072‑9752(08)02131‑3 19892134
     [Google Scholar]
  8. KamdarF. GarryD.J. Dystrophin-Deficient Cardiomyopathy.J. Am. Coll. Cardiol.201667212533254610.1016/j.jacc.2016.02.081 27230049
     [Google Scholar]
  9. DarrasB.T. UrionD.K. GhoshP.S. Dystrophinopathies.GeneReviews®. Seattle, WA.University of Washington Seattle200019932024
     [Google Scholar]
  10. NguyenK. PutouxA. BusaT. Incidental findings on array comparative genomic hybridization: Detection of carrier females of dystrophinopathy without any family history.Clin. Genet.201587548849110.1111/cge.12421 24835530
     [Google Scholar]
  11. FratterC. DalgleishR. AllenS.K. EMQN best practice guidelines for genetic testing in dystrophinopathies.Eur. J. Hum. Genet.20202891141115910.1038/s41431‑020‑0643‑7 32424326
     [Google Scholar]
  12. SarkozyA. QuinlivanR. BourkeJ.P. 263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: Refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022.Neuromuscul. Disord.202333327428410.1016/j.nmd.2023.01.003 36804616
     [Google Scholar]
  13. Johansen TaberK. Ben-ShacharR. TorresR. A guidelines-consistent carrier screening panel that supports equity across diverse populations.Genet. Med.202224120121310.1016/j.gim.2021.09.009 34906503
     [Google Scholar]
  14. SingerA. Aartsma-RusA. Grinshpun-CohenJ. Sagi-DainL. Lessons learned from the first national population-based genetic carrier-screening program for Duchenne muscular dystrophy.Genet. Med.2023251210098110.1016/j.gim.2023.100981 37712502
     [Google Scholar]
  15. CohenG. Shtorch-AsorA. Ben-ShacharS. Large scale population screening for Duchenne muscular dystrophy—Predictable and unpredictable challenges.Prenat. Diagn.20224291162117210.1002/pd.6201 35751502
     [Google Scholar]
  16. Juan-MateuJ. RodríguezM.J. NascimentoA. Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.Orphanet J. Rare Dis.2012718210.1186/1750‑1172‑7‑82 23092449
     [Google Scholar]
  17. ViggianoE. PicilloE. CirilloA. PolitanoL. Comparison of X‐chromosome inactivation in Duchenne muscle/myocardium‐manifesting carriers, non‐manifesting carriers and related daughters.Clin. Genet.201384326527010.1111/cge.12048 23110537
     [Google Scholar]
  18. IshizakiM. KobayashiM. AdachiK. MatsumuraT. KimuraE. Female dystrophinopathy: Review of current literature.Neuromuscul. Disord.201828757258110.1016/j.nmd.2018.04.005 29801751
     [Google Scholar]
  19. PolitanoL. NigroV. NigroG. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies.JAMA1996275171335133810.1001/jama.1996.03530410049032 8614119
     [Google Scholar]
  20. SolheimT.Å. FornanderF. RajaA.A. Cardiac involvement in women with pathogenic dystrophin gene variants.Front. Neurol.20211270783810.3389/fneur.2021.707838 34385974
     [Google Scholar]
  21. UedaY. KawaiH. AdachiK. NaruoT. SaitoS. [Cardiac dysfunction in female gene carriers of Duchenne muscular dystrophy].Rinsho Shinkeigaku1995351111911198 8720327
     [Google Scholar]
  22. FornanderF. SolheimT.Å. EisumA.S.V. Quantitative muscle MRI and clinical findings in women with pathogenic dystrophin gene variants.Front. Neurol.20211270783710.3389/fneur.2021.707837 34539555
     [Google Scholar]
  23. LeeS.H. LeeJ.H. LeeK.A. ChoiY.C. Clinical and genetic characterization of female dystrophinopathy.J. Clin. Neurol.201511324825110.3988/jcn.2015.11.3.248 26022459
     [Google Scholar]
  24. GilibertoF. RadicC.P. LuceL. FerreiroV. de BrasiC. SzijanI. Symptomatic female carriers of Duchenne muscular dystrophy (DMD): Genetic and clinical characterization.J. Neurol. Sci.20143361-2364110.1016/j.jns.2013.09.036 24135430
     [Google Scholar]
  25. LiuC. MaJ. LuY. Clinical, pathological, and genetic characterization in a large Chinese cohort with female dystrophinopathy.Neuromuscul. Disord.2023331072873610.1016/j.nmd.2023.08.008 37716855
     [Google Scholar]
  26. AdachiK. KawaiH. SaitoM. Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy.Intern. Med.199736749750010.2169/internalmedicine.36.497 9240500
     [Google Scholar]
  27. HoogerwaardE.M. van der WouwP.A. WildeA.A.M. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy.Neuromuscul. Disord.19999534735110.1016/S0960‑8966(99)00018‑8 10407858
     [Google Scholar]
  28. IwaseT. TakaoS. AkaikeM. Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy.Heart Asia201021525510.1136/ha.2010.002006 27325943
     [Google Scholar]
  29. HoogerwaardE.M. BakkerE. IppelP.F. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: A cohort study.Lancet199935391702116211910.1016/S0140‑6736(98)10028‑4 10382696
     [Google Scholar]
  30. MelaciniP. FaninM. AngeliniA. Cardiac transplantation in a Duchenne muscular dystrophy carrier.Neuromuscul. Disord.19988858559010.1016/S0960‑8966(98)00071‑6 10093066
     [Google Scholar]
  31. DaviesJ.E. WinokurT.S. AaronM.F. BenzaR.L. FoleyB.A. HolmanW.L. Cardiomyopathy in a carrier of duchenne’s muscular dystrophy.J. Heart Lung Transplant.200120778178410.1016/S1053‑2498(00)00240‑0 11448811
     [Google Scholar]
  32. CullomC. VoV. McCabeM.D. Orthotopic heart transplantation in manifesting carrier of duchenne muscular dystrophy.J. Cardiothorac. Vasc. Anesth.20223688 Pt A2593259910.1053/j.jvca.2021.09.047 34670720
     [Google Scholar]
  33. FeingoldB. MahleW.T. AuerbachS. Management of cardiac involvement associated with neuromuscular diseases: A scientific statement from the american heart association.Circulation201713613e200e23110.1161/CIR.0000000000000526 28838934
     [Google Scholar]
  34. BogueL. PeayH. MartinA. LucasA. RamchandrenS. Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy.Neuromuscul. Disord.2016261286086410.1016/j.nmd.2016.09.008 27863875
     [Google Scholar]
  35. EekhoffL. EdwardsJ. MartinA. PrijolesE.J. Assessing the barriers to cardiac care in carriers of Duchenne and Becker muscular dystrophy.J. Genet. Couns.2019285993100210.1002/jgc4.1151 31373078
     [Google Scholar]
  36. HoefelA.M.L. WeschenfelderC.A. RosaB.F. DonisK.C. SauteJ.A.M. Empowerment of genetic information by women at-risk of being carriers of Duchenne and Becker muscular dystrophies.J. Community Genet.202415216317510.1007/s12687‑023‑00695‑3 38165635
     [Google Scholar]
  37. LimK.R.Q. SheriN. NguyenQ. YokotaT. Cardiac involvement in dystrophin-deficient females: Current understanding and implications for the treatment of dystrophinopathies.Genes (Basel)202011776510.3390/genes11070765 32650403
     [Google Scholar]
  38. ThomasG.D. Functional muscle ischemia in Duchenne and Becker muscular dystrophy.Front. Physiol.2013438110.3389/fphys.2013.00381 24391598
     [Google Scholar]
  39. DombernowskyN.W. ÖlmestigJ.N.E. WittingN. KruuseC. Role of neuronal nitric oxide synthase (nNOS) in Duchenne and Becker muscular dystrophies – Still a possible treatment modality?Neuromuscul. Disord.2018281191492610.1016/j.nmd.2018.09.001 30352768
     [Google Scholar]
  40. GrainL. Cortina-BorjaM. ForfarC. Hilton-JonesD. HopkinJ. BurchM. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.Neuromuscul. Disord.200111218619110.1016/S0960‑8966(00)00185‑1 11257476
     [Google Scholar]
  41. MccaffreyT. GuglieriM. MurphyA.P. BushbyK. JohnsonA. BourkeJ.P. Cardiac involvement in female carriers of duchenne or becker muscular dystrophy.Muscle Nerve201755681081810.1002/mus.25445 27761893
     [Google Scholar]
  42. KinclV. PanovskýR. PešlM. Echocardiographic signs of subclinical cardiac function impairment in Duchenne dystrophy gene carriers.Sci. Rep.20201012079410.1038/s41598‑020‑77882‑6 33247228
     [Google Scholar]
  43. AdachiK. HashiguchiS. SaitoM. Detection and management of cardiomyopathy in female dystrophinopathy carriers.J. Neurol. Sci.2018386748010.1016/j.jns.2017.12.024 29358000
     [Google Scholar]
  44. van WestrumS.M.S. HoogerwaardE.M. DekkerL. Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy.Neurology2011771626610.1212/WNL.0b013e318221ad14 21700587
     [Google Scholar]
  45. LiuC. FerrariV.A. HanY. Cardiovascular magnetic resonance imaging and heart failure.Curr. Cardiol. Rep.20212343510.1007/s11886‑021‑01464‑9 33686516
     [Google Scholar]
  46. FlorianA. RöschS. BietenbeckM. Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: A comparative cardiovascular magnetic resonance study.Eur. Heart J. Cardiovasc. Imaging201617332633310.1093/ehjci/jev161 26113120
     [Google Scholar]
  47. WexbergP. AvanziniM. MascherbauerJ. Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers.J. Cardiovasc. Magn. Reson.20161816110.1186/s12968‑016‑0281‑y 27660108
     [Google Scholar]
  48. MasárováL. PanovskýR. PešlM. Myocardial native T1 mapping and extracellular volume quantification in asymptomatic female carriers of Duchenne muscular dystrophy gene mutations.Orphanet J. Rare Dis.202318128310.1186/s13023‑023‑02899‑9 37697356
     [Google Scholar]
  49. TangL. ShaoS. WangC. Electrocardiographic features of children with Duchenne muscular dystrophy.Orphanet J. Rare Dis.202217132010.1186/s13023‑022‑02473‑9 35987773
     [Google Scholar]
  50. MahM.L. CripeL. SlawinskiM.K. Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing.Int. J. Cardiol.202031625726510.1016/j.ijcard.2020.05.052 32473283
     [Google Scholar]
  51. AzzuA. AntonopoulosA.S. KrupickovaS. Myocardial strain analysis by cardiac magnetic resonance 3D feature-tracking identifies subclinical abnormalities in patients with neuromuscular disease and no overt cardiac involvement.Eur. Heart J. Cardiovasc. Imaging202324450351110.1093/ehjci/jeac129 35793360
     [Google Scholar]
  52. KondoT. OkumuraT. TakefujiM. Long-term pathological follow-up of myocardium in a carrier of duchenne muscular dystrophy with dilated cardiomyopathy.Circ. Heart Fail.2017103e00382610.1161/CIRCHEARTFAILURE.117.003826 28235759
     [Google Scholar]
  53. MavrogeniS. BratisK. PapavasiliouA. CMR detects subclinical cardiomyopathy in mother-carriers of Duchenne and Becker muscular dystrophy.JACC Cardiovasc. Imaging20136452652810.1016/j.jcmg.2012.09.017 23579015
     [Google Scholar]
  54. GiglioV. PudduP.E. CamastraG. Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.J. Cardiovasc. Magn. Reson.20141614510.1186/1532‑429X‑16‑45 25008475
     [Google Scholar]
  55. SchelhornJ. SchoeneckerA. NeudorfU. Cardiac pathologies in female carriers of Duchenne muscular dystrophy assessed by cardiovascular magnetic resonance imaging.Eur. Radiol.201525103066307210.1007/s00330‑015‑3694‑3 25791640
     [Google Scholar]
  56. LangS.M. ShughS. MazurW. Myocardial Fibrosis and left ventricular dysfunction in duchenne muscular dystrophy carriers using cardiac magnetic resonance imaging.Pediatr. Cardiol.20153671495150110.1007/s00246‑015‑1192‑7 25976773
     [Google Scholar]
  57. HanS. XuH. ZhengJ. Population-wide duchenne muscular dystrophy carrier detection by CK and molecular testing.BioMed Res. Int.2020202011210.1155/2020/8396429 33029525
     [Google Scholar]
  58. FortunatoF. FerliniA. Biomarkers in Duchenne Muscular Dystrophy: Current status and future directions.J. Neuromuscul. Dis.2023106987100210.3233/JND‑221666 37545256
     [Google Scholar]
  59. ArmstrongN. ApkonS. BerggrenK.N. The early care (0–3 years) in duchenne muscular dystrophy meeting report.J. Neuromuscul. Dis.20241121910.3233/JND‑230180 38189762
     [Google Scholar]
  60. SpurneyC.F. AscheimD. CharnasL. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: Review and recommendations from the Parent Project Muscular Dystrophy expert panel.Open Heart202181e00159210.1136/openhrt‑2021‑001592 33762424
     [Google Scholar]
  61. FlorianA. PatrascuA. TremmelR. Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in muscular dystrophy female carriers using a complementary cardiac imaging and plasma profiling approach.Front. Physiol.20189177010.3389/fphys.2018.01770 30622476
     [Google Scholar]
  62. MousaN.O. AbdellatifA. FahmyN. ZadaS. El-FawalH. OsmanA. Circulating MicroRNAs in Duchenne Muscular Dystrophy.Clin. Neurol. Neurosurg.202018910563410.1016/j.clineuro.2019.105634 31838454
     [Google Scholar]
  63. HeidenreichP.A. BozkurtB. AguilarD. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation202214518e895e103210.1161/CIR.0000000000001063 35363499
     [Google Scholar]
  64. McDonaghT.A. MetraM. AdamoM. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur. J. Heart Fail.202426151710.1002/ejhf.3024 38169072
     [Google Scholar]
  65. FinstererJ. StöllbergerC. FreudenthalerB. De SimoniD. HöftbergerR. WagnerK. Muscular and cardiac manifestations in a Duchenne-carrier harboring a <i>dystrophin</i> deletion of exons 12-29.Intractable Rare Dis. Res.20187212012510.5582/irdr.2018.01003 29862154
     [Google Scholar]
  66. EarlC.C. SoslowJ.H. MarkhamL.W. GoergenC.J. Myocardial strain imaging in Duchenne muscular dystrophy.Front. Cardiovasc. Med.20229103120510.3389/fcvm.2022.1031205 36505382
     [Google Scholar]
/content/journals/ccr/10.2174/011573403X292850240719074112
Loading
Heart Disease in Mothers of Children with Duchenne Muscular Dystrophy
Current Cardiology Reviews 20, E230724232195 (2024); https://doi.org/10.2174/011573403X292850240719074112
/content/journals/ccr/10.2174/011573403X292850240719074112
/content/journals/ccr/10.2174/011573403X292850240719074112
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): cardiomyopathy; Duchenne muscular dystrophy; female carriers; health management; Heart disease

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test